2ND CANCER FOLLOWING CHEMOTHERAPY AND RADIOTHERAPY - AN EPIDEMIOLOGIC PERSPECTIVE

被引:25
作者
KALDOR, J
机构
[1] The International Agency For Research On Cancer, Lyon
关键词
Cancer chemotherapy; Carcinogenesis; Epidemiology; Radiation;
D O I
10.3109/02841869009090070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Both ionizing radiation and alkylating chemicals are used to treat cancer, and both are themselves carcinogenic. Epidemiological methods of study have provided a substantial amount of information on the long-term risks of the two types of treatment. Radiotherapy appears to increase the risk of a wide range of cancers, but the size of the increase is not substantial. Chemotherapy, in contrast, produces a very large increase in the risk of acute leukaemia, and does not generally appear to produce other types of cancer. Leukaemias following both treatment modalities appear rapidly, while the risk of solid tumours induced by radiotherapy is not manifested until a decade or more has elapsed. There does not seem to be synergy between the two types of therapy in their carcinogenic action. Continued use of the epidemiological approach is essential in risk-benefit evaluation of cancer therapy. ©1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:647 / 655
页数:9
相关论文
共 15 条
[1]  
[Anonymous], 1988, SOURCES EFFECTS RISK
[2]   RADIATION-DOSE AND SECOND CANCER RISK IN PATIENTS TREATED FOR CANCER OF THE CERVIX [J].
BOICE, JD ;
ENGHOLM, G ;
KLEINERMAN, RA ;
BLETTNER, M ;
STOVALL, M ;
LISCO, H ;
MOLONEY, WC ;
AUSTIN, DF ;
BOSCH, A ;
COOKFAIR, DL ;
KREMENTZ, ET ;
LATOURETTE, HB ;
MERRILL, JA ;
PETERS, LJ ;
SCHULZ, MD ;
STORM, HH ;
BJORKHOLM, E ;
PETTERSSON, F ;
BELL, CMJ ;
COLEMAN, MP ;
FRASER, P ;
NEAL, FE ;
PRIOR, P ;
CHOI, NW ;
HISLOP, TG ;
KOCH, M ;
KREIGER, N ;
ROBB, D ;
ROBSON, D ;
THOMSON, DH ;
LOCHMULLER, H ;
VONFOURNIER, D ;
FRISCHKORN, R ;
KJORSTAD, KE ;
RIMPELA, A ;
PEJOVIC, MH ;
KIRN, VP ;
STANKUSOVA, H ;
BERRINO, F ;
SIGURDSSON, K ;
HUTCHISON, GB ;
MACMAHON, B .
RADIATION RESEARCH, 1988, 116 (01) :3-55
[3]  
BOICE JD, 1985, J NATL CANCER I, V74, P955
[4]  
BOICE JD, 1987, J NATL CANCER I, V79, P1295
[5]  
Curtis R E, 1985, Natl Cancer Inst Monogr, V68, P219
[6]   INCIDENCE OF 2ND PRIMARY TUMORS AMONG CHILDHOOD-CANCER SURVIVORS [J].
HAWKINS, MM ;
DRAPER, GJ ;
KINGSTON, JE .
BRITISH JOURNAL OF CANCER, 1987, 56 (03) :339-347
[7]   LEUKEMIA FOLLOWING CHEMOTHERAPY FOR OVARIAN-CANCER [J].
KALDOR, JM ;
DAY, NE ;
PETTERSSON, F ;
CLARKE, EA ;
PEDERSEN, D ;
MEHNERT, W ;
BELL, J ;
HOST, H ;
PRIOR, P ;
KARJALAINEN, S ;
NEAL, F ;
KOCH, M ;
BAND, P ;
CHOI, W ;
KIRN, VP ;
ARSLAN, A ;
ZAREN, B ;
BELCH, AR ;
STORM, H ;
KITTELMANN, B ;
FRASER, P ;
STOVALL, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :1-6
[8]   LEUKEMIA FOLLOWING HODGKINS-DISEASE [J].
KALDOR, JM ;
DAY, NE ;
CLARKE, EA ;
VANLEEUWEN, FE ;
HENRYAMAR, M ;
FIORENTINO, MV ;
BELL, J ;
PEDERSEN, D ;
BAND, P ;
ASSOULINE, D ;
KOCH, M ;
CHOI, W ;
PRIOR, P ;
BLAIR, V ;
LANGMARK, F ;
KIRN, VP ;
NEAL, F ;
PETERS, D ;
PFEIFFER, R ;
KARJALAINEN, S ;
CUZICK, J ;
SUTCLIFFE, SB ;
SOMERS, R ;
PELLAECOSSET, B ;
PAPPAGALLO, GL ;
FRASER, P ;
STORM, H ;
STOVALL, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :7-13
[9]   RISK OF THERAPY-RELATED LEUKEMIA AND PRELEUKEMIA AFTER HODGKINS-DISEASE - RELATION TO AGE, CUMULATIVE DOSE OF ALKYLATING-AGENTS, AND TIME FROM CHEMOTHERAPY [J].
PEDERSENBJERGAARD, J ;
LARSEN, SO ;
STRUCK, J ;
HANSEN, HH ;
SPECHT, L ;
ERSBOLL, J ;
HANSEN, MM ;
NISSEN, NI .
LANCET, 1987, 2 (8550) :83-88
[10]   RISK OF 2ND CANCERS AFTER TREATMENT FOR HODGKINS-DISEASE [J].
TUCKER, MA ;
COLEMAN, CN ;
COX, RS ;
VARGHESE, A ;
ROSENBERG, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (02) :76-81